Infantile hemangioma models: is the needle in a haystack?

M Kong, Y Li, K Wang, S Zhang, Y Ji - Journal of translational medicine, 2023 - Springer
Infantile hemangioma (IH) is the most prevalent benign vascular tumor in infants, with
distinct disease stages and durations. Despite the fact that the majority of IHs can regress …

Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression

F Pascarella, RT Scaramuzzo, A Pini… - Frontiers in …, 2024 - frontiersin.org
Despite the evident progress in neonatal medicine, retinopathy of prematurity (ROP)
remains a serious threat to the vision of premature infants, due to a still partial understanding …

[HTML][HTML] Apelin receptor can act as a specific marker and promising therapeutic target for infantile hemangioma

Q Chen, H Ying, Z Yu, L Chang, Z Chen, J Chen… - Journal of Investigative …, 2023 - Elsevier
Infantile hemangioma (IH), the most common benign tumor in infancy, is generally sensitive
to propranolol treatment. However, the challenge remains because resistance or recurrence …

Apolipoprotein AI Binding Protein Inhibits the Formation of Infantile Hemangioma through Cholesterol-Regulated Hypoxia-Inducible Factor 1α Activation

Y Jiang, X Li, Q Liu, G Lei, C Wu, L Chen… - Journal of Investigative …, 2024 - Elsevier
Infantile hemangioma (IH) is the most frequent vascular tumor of infancy with unclear
pathogenesis; disordered angiogenesis is considered to be involved in its formation …

Murine Models of Infantile Hemangioma: A Comprehensive Review

WJ Nie, XY Zhang, YT Xia, B Jiang, Z Cai… - International Journal of …, 2024 - mednexus.org
Infantile hemangioma is the most common benign vascular tumor of infancy and is
characterized by a unique life cycle. Animal models that reflect the histological and …